Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Sale!
Benitrobenrazide
AOB14436
CAS: 2454676-05-0
Chemical Name: BNBZ; (E)-4-Nitro-N'-(2,3,4-trihydroxybenzylidene)benzohydrazide
1892 Items
In stock
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $24.65 | Total: $123.25 |
| 1 | 10 | $20.88 | Total: $208.80 |
| 1 | 25 | $17.69 | Total: $442.25 |
| 1 | 50 | $15.08 | Total: $754.00 |
| 1 | 100 | $13.05 | Total: $1,305.00 |
Overview
Novel selective hexokinase 2 (HK2) inhibitor, blocking cancer cells growth by targeting glycolysis
Chemical Properties
| Molecular Formula | C14H11N3O6 |
| Molecular Weight | 317.26 |
| CAS Numbers | 2454676-05-0 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| IUPAC/Chemical Name | (E)-4-nitro-N'-(2,3,4-trihydroxybenzylidene)benzohydrazide |
| InChl Key | OQNGYRBQYWPKIC-VIZOYTHASA-N |
| InChl Code | InChI=1S/C14H11N3O6/c18-11-6-3-9(12(19)13(11)20)7-15-16-14(21)8-1-4-10(5-2-8)17(22)23/h1-7,18-20H,(H,16,21)/b15-7+ |
| SMILES Code | O=C(N/N=C/C1=CC=C(O)C(O)=C1O)C2=CC=C([N+]([O-])=O)C=C2 |
Storage and Handling
0°C (short term), -20°C (long term), desiccated
Synonyms
Benitrobenrazide; BNBZ;
References
1) Zheng M, Wu C, Yang K, Yang Y, Liu Y, Gao S, Wang Q, Li C, Chen L, Li H. Novel selective hexokinase 2 inhibitor Benitrobenrazide blocks cancer cells growth by targeting glycolysis. Pharmacol Res. 2020 Dec 8:105367. doi: 10.1016/j.phrs.2020.105367. Epub ahead of print. PMID: 33307221.